Cargando…

Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury

Renal ischemia and reperfusion (I/R) is the major cause of acute kidney injury in hospitalized patients. Mechanisms underlying reperfusion-associated injury include recruitment and activation of leukocytes and release of inflammatory mediators. In this study, we investigated the renal effects of acu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barroso, Lívia Corrêa, Silveira, Kátia Daniela, Lima, Cristiano Xavier, Borges, Valdinéria, Bader, Michael, Rachid, Milene, Santos, Robson Augusto Souza, Souza, Danielle Gloria, Simões e Silva, Ana Cristina, Teixeira, Mauro Martins
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272821/ https://www.ncbi.nlm.nih.gov/pubmed/22319645 http://dx.doi.org/10.1155/2012/808726

Ejemplares similares

AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation
por: Jiang, Teng, et al.
Publicado: (2018)

AVE0991, a Nonpeptide Angiotensin 1-7 Receptor Agonist, Improves Glucose Metabolism in the Skeletal Muscle of Obese Zucker Rats: Possible Involvement of Prooxidant/Antioxidant Mechanisms
por: Dobrocsyova, Viktoria, et al.
Publicado: (2020)

Mas Receptor Agonist AVE0991 increases surfactant protein expression under hyperoxic conditions in human lung epithelial cells
por: Thiruvenkataramani, Ranga Prasanth, et al.
Publicado: (2020)

Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
por: Klein, Sabine, et al.
Publicado: (2015)

Evaluation of the cardioprotective and antihypertensive effect of AVE 0991 in normotensive and hypertensive rats
por: da Silva, Matheus Vinicius Barbosa, et al.
Publicado: (2022)

AVE0991, a Nonpeptide Compound, Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation via Induction of Heme Oxygenase-1 and Downregulation of p-38 MAPK Phosphorylation
por: Sheng-Long, Chen, et al.
Publicado: (2012)

AVE 0991 Suppresses Astrocyte-Mediated Neuroinflammation of Alzheimer’s Disease by Enhancing Autophagy
por: Deng, Yang, et al.
Publicado: (2023)

AVE 0991 attenuates oxidative stress and neuronal apoptosis via Mas/PKA/CREB/UCP-2 pathway after subarachnoid hemorrhage in rats
por: Mo, Jun, et al.
Publicado: (2018)

The effect of AVE 0991, nebivolol and doxycycline on inflammatory mediators in an apoE-knockout mouse model of atherosclerosis
por: Jawien, Jacek, et al.
Publicado: (2012)

Beneficial Effects of the Activation of the Angiotensin-(1–7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy
por: Silveira, Kátia Daniela, et al.
Publicado: (2013)

AVE 0991 Attenuates Pyroptosis and Liver Damage after Heatstroke by Inhibiting the ROS-NLRP3 Inflammatory Signalling Pathway
por: Zhang, Ming, et al.
Publicado: (2019)

Anti‐atherosclerotic effect of the angiotensin 1–7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis
por: Skiba, D S, et al.
Publicado: (2017)

Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist
por: Erickson-Miller, Connie L, et al.
Publicado: (2009)

A Nonpeptide Oxytocin Receptor Agonist for a Durable Relief of Inflammatory Pain
por: Hilfiger, Louis, et al.
Publicado: (2020)

In vitro pharmacological characterization of a novel unbiased NOP receptor‐selective nonpeptide agonist AT‐403
por: Ferrari, Federica, et al.
Publicado: (2017)

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist
por: Kawai, Takahiro, et al.
Publicado: (2020)

A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinism
por: Juliana, Christine A., et al.
Publicado: (2023)

The Non-peptide Angiotensin-(1–7) Mimic AVE 0991 Attenuates Delayed Neurocognitive Recovery After Laparotomy by Reducing Neuroinflammation and Restoring Blood-Brain Barrier Integrity in Aged Rats
por: Mi, Xinning, et al.
Publicado: (2021)

Nonpeptide Small Molecule Agonist and Antagonist Original Leads for Neuropeptide FF1 and FF2 Receptors
por: Journigan, V. Blair, et al.
Publicado: (2014)

Mycobacterium tuberculosis Rv0991c Is a Redox-Regulated Molecular Chaperone
por: Becker, Samuel H., et al.
Publicado: (2020)

The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
por: Thomas, M. C., et al.
Publicado: (2012)

Glucagon-producing cells are increased in Mas-deficient mice
por: Felix Braga, Janaína, et al.
Publicado: (2016)

Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures
por: Merlino, Francesco, et al.
Publicado: (2013)

Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor
por: Giorgioni, Gianfabio, et al.
Publicado: (2022)

SAT-169 Selective Nonpeptide Somatostatin Subtype 5 (sst5) Agonists Suppress Glucose- and Sulfonylurea-Induced Insulin Secretion in Rats
por: Sturchler, Emmanuel, et al.
Publicado: (2019)

MON-089 Discovery and Identification of Late Stage Selective Nonpeptide Somatostatin Subtype 5 (sst5) Agonists for the Treatment of Hyperinsulinemic Hypoglycemia
por: Fowler, Melissa A, et al.
Publicado: (2020)

Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers
por: Madan, Ajay, et al.
Publicado: (2022)

Renoprotective effects of a novel cMet agonistic antibody on kidney fibrosis
por: Kim, Yong Chul, et al.
Publicado: (2019)

0991. Nebulized heparin reduces pulmonary inflammatory responses in a rat model of acute lung injury
por: Chimenti, L, et al.
Publicado: (2014)

Angiotensin-(1-7) and Mas: A Brief History
por: Alenina, Natalia, et al.
Publicado: (2015)

Targeting Staphylococcus aureus Quorum Sensing with Nonpeptidic Small Molecule Inhibitors
por: Murray, Ewan J., et al.
Publicado: (2014)

PSUN304 CRN04777 an Oral, Nonpeptide SST5-selective Somatostatin Agonist Dose Dependently Suppresses Basal and Stimulated Insulin Secretion
por: Ferrara-Cook, Christine, et al.
Publicado: (2022)

Angiotensin-(1–7) Analogue AVE0991 Modulates Astrocyte-Mediated Neuroinflammation via lncRNA SNHG14/miR-223-3p/NLRP3 Pathway and Offers Neuroprotection in a Transgenic Mouse Model of Alzheimer's Disease
por: Duan, Rui, et al.
Publicado: (2021)

The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome
por: Verbrugghe, Peter, et al.
Publicado: (2018)

Pharmacophore Modeling and Docking Studies on Some Nonpeptide-Based Caspase-3 Inhibitors
por: Sharma, Simant, et al.
Publicado: (2013)

Aves
por: Taylor, Barbara, 1954-
Publicado: (1998)

Antioxidants as Renoprotective Agents for Ischemia during Partial Nephrectomy
por: Buys-Gonçalves, Gabriela F., et al.
Publicado: (2019)

Renoprotective effects of garlic
por: Nasri, Hamid
Publicado: (2013)

Renoprotective effects of metformin
por: Nasri, Running Hamid
Publicado: (2013)

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_do6rtgj251bjkemt99v70hvbu6